D
Y. Matsuo et al.
Letter
Synlett
Catal. B: Enzym. 2017, DOI: 10.1016/j.molcatb.2017.03.009.
(d) Jhoo, J.-W.; Sang, S.; Wei, G.-J.; Lee, T. C.; Rosen, R. T.; Ho, C.-
T. J. Food Lipids 2004, 11, 89. (e) Lei, S.; Xie, M.; Hu, B.; Zhou, L.;
Sun, Y.; Saeeduddin, M.; Zhang, H.; Zeng, X. Int. J. Biol. Macro-
mol. 2017, 94, 709. (f) Teng, J.; Gong, Z.; Deng, Y.; Chen, L.; Li, Q.;
Shao, Y.; Lin, L.; Xiao, W. LWT – Food Sci. Technol. 2017, 84, 263.
(11) Sang, S.; Lambert, J. D.; Tian, S.; Hong, J.; Hou, Z.; Ryu, J.-H.;
Stark, R. E.; Rosen, R. T.; Huang, M.-T.; Yang, C. S.; Ho, C.-T.
Bioorg. Med. Chem. 2004, 12, 459.
(12) (a) Tanaka, T.; Mine, C.; Inoue, K.; Matsuda, M.; Kouno, I. J. Agric.
Food Chem. 2002, 50, 2142. (b) Van Der Westhuizen, M.;
Steenkamp, L.; Steenkamp, P.; Apostolides, Z. Biocatal. Biotrans-
form. 2015, 33, 298.
(13) Takemoto, M.; Takemoto, H.; Sakurada, A. Tetrahedron Lett.
2014, 55, 5038.
(14) Yoruk, R.; Marshall, M. R. J. Food Biochem. 2003, 27, 361.
(15) Qi, X. Fitoterapia 2010, 81, 205.
(16) Yanase, E.; Matsumoto, E.; Shinoda, Y.; Nakatsuka, S. ITE Lett.
Batteries, New Technol. Med. 2005, 6, 232.
(17) (a) Kawabe, Y.; Aihara, Y.; Hirose, Y.; Sakurada, A.; Yoshida, A.;
Inai, M.; Asakawa, T.; Hamashima, Y.; Kan, T. Synlett 2013, 24,
479. (b) Asakawa, T.; Kawabe, Y.; Yoshida, A.; Aihara, Y.;
Manabe, T.; Hirose, Y.; Sakurada, A.; Inai, M.; Hamashima, Y.;
Furuta, T.; Wakimoto, T.; Kan, T. J. Antibiot. 2016, 69, 299.
(18) Sawai, Y.; Sakata, K. J. Agric. Food Chem. 1998, 46, 111.
(19) The kinetic and mechanistic studies for the oxidation of cate-
chol derivatives including 5 and 9 by DPPH radical were also
reported: (a) Suzuki, M.; Mori, M.; Nanjo, F.; Hara, Y. In Caffein-
ated Beverages, Health Benefits, Physiological Effects, and Chemis-
column of MCI-gel CHP20P (3.0 × 24 cm; 0–80% aq MeOH, 10%
stepwise, each 200 mL) to afford a crude theaflavin (1) fraction
along with 5 (154 mg, 77%). The crude fraction of 1 was purified
with Sephadex LH-20 (3.0 × 20 cm; 40–100% aq MeOH, 10%
stepwise, each 200 mL) to afford 14c,d,11,22 (91.3 mg, 0.16 mmol,
47% from 7) and theanaphthoquinone (10)23 (2.9 mg, 0.0054
mmol, 1.6% from 7).
Analytical Data for Theaflavin (1)
Reddish-orange amorphous powder, [α]D –234 (c 0.105,
25
MeOH). FAB-MS: m/z = 565 [M + H]+, 587 [M + Na]+. HRMS–FAB:
m/z calcd for C29H25O12: 565.1346; found: 565.1340 [M + H]+. IR:
3406, 2935, 1627, 1604, 1518, 1470, 1419, 1310, 1227 cm–1. UV
(MeOH): λmax (log ε) = 462 (3.49), 378 (3.90), 267 (4.27). 1H NMR
(400 MHz, acetone-d6 + D2O, 95:5): δ = 8.00 (s, H-g), 7.93 (s, H-
e), 7.53 (s, H-c), 6.04 (d, J = 2.2 Hz, H-6′), 6.02 (d, J = 2.4 Hz, H-6),
5.99 (d, J = 2.2 Hz, H-8′), 5.95 (d, J = 2.4 Hz, H-8), 5.69 (s, H-2′),
4.98 (s, H-2), 4.45 (m, H-3′), 4.36 (m, H-3), 2.95 (dd, J = 16.8, 4.4
Hz, H-4′a), 2.89 (dd, J = 16.8, 4.4 Hz, H-4a), 2.80 (dd, J = 16.8, 2.3
Hz, H-4b), 2.77 (br d, J = 16.8 Hz, H-4′b). 13C NMR (100 MHz,
acetone-d6 + D2O, 95:5): δ = 185.1 (C-a), 157.8, 157.7, 157.6,
157.5 (C-5, 7, 5′, 7′), 157.0 (C-8′a), 156.5 (C-8a), 154.6 (C-b),
150.4 (C-i), 146.1 (C-h), 135.0 (C-d), 131.7 (C-f), 128.6 (C-k),
126.9 (C-e), 123.9 (C-g), 121.7 (C-j), 118.9 (C-c), 99.8 (C-4′a),
99.3 (C-4a), 96.5 (2 C, C-6, 6′), 95.6 (C-8′), 95.3 (C-8), 81.2 (C-2),
76.6 (C-2′), 66.2 (C-3), 65.0 (C-3′), 29.5 (C-4′), 29.2 (C-4).
(22) (a) Davis, A. L.; Cai, Y.; Davies, A. P. Magn. Reson. Chem. 1995, 33,
549. (b) Nonaka, G.; Hashimoto, F.; Nishioka, I. Chem. Pharm.
Bull. 1986, 34, 61.
(23) (a) Tanaka, T.; Betsumiya, Y.; Mine, C.; Kouno, I. Chem. Commun.
2000, 1365. (b) Jhoo, J.-W.; Lo, C.-Y.; Li, S.; Sang, S.; Ang, C. Y. W.;
Heinze, T. M.; Ho, C.-T. J. Agric. Food Chem. 2005, 53, 6146.
(24) Balentine, D. A.; Wiseman, S. A.; Bouwens, L. C. M. Crit. Rev. Food
Sci. Nutr. 1997, 37, 693.
(25) (a) Bentley, R. Nat. Prod. Rep. 2008, 25, 118. (b) Liu, N.; Song, W.;
Schienebeck, C. M.; Zhang, M.; Tang, W. Tetrahedron 2014, 70,
9281.
(26) (a) Nierenstein, M.; Swanton, A. Biochem. J. 1944, 38, 373.
(b) Barltrop, J. A.; Nicholson, J. S. J. Chem. Soc. 1948, 116.
(27) Arpin, N.; Favre-Bonvin, J.; Steglich, W. Phytochemistry 1974, 13,
1949.
(28) Klostermeyer, D.; Knops, L.; Sindlinger, T.; Polborn, K.; Steglich,
W. Eur. J. Org. Chem. 2000, 603.
try; Parliment, T. H.; Ho, C. T.; Schieberle, P., Eds.;
7
V5o4.
l
ACS Sympo-
sium Series, American Chemical Society: Washington, DC, 2000,
146. (b) Goupy, P.; Dufour, C.; Loonis, M.; Dangles, O. J. Agric.
Food Chem. 2003, 51, 615. (c) Dangles, O.; Fargeix, G.; Dufour, C.
J. Chem. Soc., Perkin Trans. 2 2000, 1653. (d) Chen, W.-L.; Li, W.-
S.; Fu, P.-J.; Yeh, A. Int. J. Chem. Kinet. 2011, 43, 147. (e) Lin, L.-
M.; Li, W.-S.; Chen, W.-L.; Yeh, A. J. Chin. Chem. Soc. 2010, 57,
883.
(20) Currently, we are investigating the structure of the bicy-
clo[3.2.1]octane intermediate by converting it into a stable
derivative. The details will be reported in the near future.
(21) Experimental Procedure for Synthesis of Theaflavin (1)
DPPH (543 mg, 1.4 mmol) was added to an acetone solution
(100 mL) of epicatechin (5, 200 mg, 0.69 mmol). After stirring
for 1 h at r.t., an acetone solution (50 mL) of epigallocatechin (7,
106 mg, 0.35 mmol) was added to the reaction mixture and
stirred for 15 min at r.t. Then, water (150 mL) was added to the
reaction mixture and stirred for 15 min. The reaction mixture
was concentrated in vacuo, and the residue was applied to a
(29) Kerschensteiner, L.; Löbermann, F.; Steglich, W.; Trauner, D. Tet-
rahedron 2011, 67, 1536.
(30) (a) Mesa-Siverio, D.; Estévez-Braun, A.; Ravelo, Á. G.; Murguia, J.
R.; Rodríguez-Afonso, A. Eur. J. Org. Chem. 2003, 4243. (b) Fukui,
N.; Ohmori, K.; Suzuki, K. Helv. Chim. Acta 2012, 95, 2194.
© Georg Thieme Verlag Stuttgart · New York — Synlett 2017, 28, A–D